128 related articles for article (PubMed ID: 1309341)
1. Spironolactone, an aldosterone antagonist, acts as an antiglucocorticosteroid on the mouse mammary tumor virus promoter.
Couette B; Marsaud V; Baulieu EE; Richard-Foy H; Rafestin-Oblin ME
Endocrinology; 1992 Jan; 130(1):430-6. PubMed ID: 1309341
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of dexamethasone 21-mesylate antiglucocorticoid action: II. Receptor-antiglucocorticoid complexes do not interact productively with mouse mammary tumor virus long terminal repeat chromatin.
Richard-Foy H; Sistare FD; Riegel AT; Simons SS; Hager GL
Mol Endocrinol; 1987 Sep; 1(9):659-65. PubMed ID: 2856414
[TBL] [Abstract][Full Text] [Related]
3. In vivo binding of proteins to stably integrated MMTV DNA in murine cell lines: occupancy of NFI and OTF1 binding sites in the absence and presence of glucocorticoids.
Härtig E; Cato AC
Cell Mol Biol Res; 1994; 40(7-8):643-52. PubMed ID: 7787882
[TBL] [Abstract][Full Text] [Related]
4. Role of chromatin structure in transcriptional regulation of MMTV LTR hormone-dependent promoter.
Richard-Foy H; Adom J; Carr K; Gouilleux F; Marsaud V; Redeuilh G; Sabbah M; Sola B
Rev Esp Fisiol; 1990 Mar; 46(1):31-7. PubMed ID: 2168572
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of glucocorticoid receptor-mediated gene expression by heat and chemical shock.
Sanchez ER; Hu JL; Zhong S; Shen P; Greene MJ; Housley PR
Mol Endocrinol; 1994 Apr; 8(4):408-21. PubMed ID: 8052262
[TBL] [Abstract][Full Text] [Related]
6. Cellular factors binding to a novel cis-acting element mediate steroid hormone responsiveness of mouse mammary tumor virus promoter.
Lee KI; Reddy EP; Reddy CD
J Biol Chem; 1995 Oct; 270(41):24502-8. PubMed ID: 7592667
[TBL] [Abstract][Full Text] [Related]
7. Generation of glucocorticoid-responsive Moloney murine leukemia virus by insertion of regulatory sequences from murine mammary tumor virus into the long terminal repeat.
Overhauser J; Fan H
J Virol; 1985 Apr; 54(1):133-44. PubMed ID: 2983110
[TBL] [Abstract][Full Text] [Related]
8. Identification of glucocorticoid receptor domains necessary for transcriptional activation of the mouse mammary tumor virus promoter integrated in the genome.
Bonovich MT; List HJ; Zhang S; Danielsen M; Riegel AT
Exp Cell Res; 1998 Mar; 239(2):454-62. PubMed ID: 9521864
[TBL] [Abstract][Full Text] [Related]
9. The establishment of the long terminal repeat of the mouse mammary tumor virus into CV-1 cells allows a functional analysis of steroid receptors.
Couette B; Le Ricousse S; Fortin D; Rafestin-Oblin ME; Richard-Foy H
Biochim Biophys Acta; 1994 Nov; 1219(3):607-12. PubMed ID: 7948018
[TBL] [Abstract][Full Text] [Related]
10. Differential steroid hormone induction of transcription from the mouse mammary tumor virus promoter.
Archer TK; Lee HL; Cordingley MG; Mymryk JS; Fragoso G; Berard DS; Hager GL
Mol Endocrinol; 1994 May; 8(5):568-76. PubMed ID: 8058066
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporin A potentiates the dexamethasone-induced mouse mammary tumor virus-chloramphenicol acetyltransferase activity in LMCAT cells: a possible role for different heat shock protein-binding immunophilins in glucocorticosteroid receptor-mediated gene expression.
Renoir JM; Mercier-Bodard C; Hoffmann K; Le Bihan S; Ning YM; Sanchez ER; Handschumacher RE; Baulieu EE
Proc Natl Acad Sci U S A; 1995 May; 92(11):4977-81. PubMed ID: 7539138
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between structural elements in hormono-regulated transcription from the mouse mammary tumor virus promoter.
Gouilleux F; Sola B; Couette B; Richard-Foy H
Nucleic Acids Res; 1991 Apr; 19(7):1563-9. PubMed ID: 1851294
[TBL] [Abstract][Full Text] [Related]
13. Tumor-promoting phorbol ester and ras oncogene expression inhibit the glucocorticoid-dependent transcription from the mouse mammary tumor virus long terminal repeat.
Vacca A; Screpanti I; Maroder M; Petrangeli E; Frati L; Gulino A
Mol Endocrinol; 1989 Oct; 3(10):1659-65. PubMed ID: 2558300
[TBL] [Abstract][Full Text] [Related]
14. Specific deactivation of the mouse mammary tumor virus long terminal repeat promoter upon continuous hormone treatment.
Boronat S; Richard-Foy H; Piña B
J Biol Chem; 1997 Aug; 272(35):21803-10. PubMed ID: 9268310
[TBL] [Abstract][Full Text] [Related]
15. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
Mymryk JS; Archer TK
Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo.
Mymryk JS; Zaniewski E; Archer TK
Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2076-80. PubMed ID: 7892227
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1.
Biola A; Lefebvre P; Perrin-Wolff M; Sturm M; Bertoglio J; Pallardy M
Mol Endocrinol; 2001 Jul; 15(7):1062-76. PubMed ID: 11435608
[TBL] [Abstract][Full Text] [Related]
18. Trans-retinoic acid and glucocorticoids synergistically induce transcription from the mouse mammary tumor virus promoter in human embryonic kidney cells.
Medh RD; Schmidt TJ
J Steroid Biochem Mol Biol; 1997 Jun; 62(2-3):129-42. PubMed ID: 9393948
[TBL] [Abstract][Full Text] [Related]
19. Purified glucocorticoid receptor-hormone complex from rat liver cytosol binds specifically to cloned mouse mammary tumor virus long terminal repeats in vitro.
Govindan MV; Spiess E; Majors J
Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5157-61. PubMed ID: 6291027
[TBL] [Abstract][Full Text] [Related]
20. Comparison of chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter by the androgen and glucocorticoid receptor.
List HJ; Lozano C; Lu J; Danielsen M; Wellstein A; Riegel AT
Exp Cell Res; 1999 Aug; 250(2):414-22. PubMed ID: 10413595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
